Literature DB >> 8361173

Blockade of prostaglandin products augments macrophage and neutrophil tumor necrosis factor synthesis in burn injury.

Y L Dong1, D N Herndon, T Z Yan, J P Waymack.   

Abstract

Cyclooxygenase products are believed to be a major regulator of host tumor necrosis factor-alpha (TNF-alpha) production in response to trauma and sepsis. To study this relationship, Lewis rats underwent a 30% burn or sham burn. Dimethyl-prostaglandin E (dPGE, 50 micrograms/kg), ibuprofen (IFU, 2 mg/kg), or saline was administered twice daily. Rats were sacrificed at Day 7 to obtain Kupffer cells, peritoneal macrophages, splenic macrophages, and neutrophils. For in vivo studies, 10(6) cells from each group were cultured with 10 micrograms of lipopolysaccharide (LPS). For in vitro studies, cells from the burn and sham groups were cultured with LPS and dPGE (10 micrograms/ml), IBU (10 micrograms/ml), or saline. The supernatants were harvested after 2, 6, and 24 hr of culture and assayed for TNF-alpha (mu/ml) by L929 cytolysis. Burn injury resulted in a significant increase in Kupffer cell and neutrophil TNF-alpha production compared to the sham group (P < 0.001, ANOVA). The administration of IBU to burned animals led to a pronounced elevation of TNF-alpha production by Kupffer cells, peritoneal macrophages, and neutrophils compared to vehicle-treated burned animals (P < 0.001, ANOVA). With in vitro studies, IBU increased Kupffer cell, peritoneal macrophage, and neutrophil TNF-alpha release by 213, 327, and 198%, respectively (P < 0.05, ANOVA). dPGE caused a marked decrease in Kupffer cell and peritoneal macrophage TNF-alpha synthesis by 50 and 43%, respectively (P < 0.01, ANOVA). In conclusion, prostaglandins are critical for down regulating TNF-alpha production. Clinical use of cyclooxygenase inhibitors may result in adverse outcomes due to the excessive TNF-alpha production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361173     DOI: 10.1006/jsre.1993.1074

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study.

Authors:  Robert Kraft; David N Herndon; Ahmed M Al-Mousawi; Felicia N Williams; Celeste C Finnerty; Marc G Jeschke
Journal:  Lancet       Date:  2012-01-31       Impact factor: 79.321

2.  Effects of lornoxicam on the physiology of severe sepsis.

Authors:  Dilek Memiş; Beyhan Karamanlioğlu; Alparslan Turan; Onur Koyuncu; Zafer Pamukçu
Journal:  Crit Care       Date:  2004-10-27       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.